GHO Capital agrees to purchase clinical research company
April 9, 2021
GHO Capital has agreed to acquire Durham, N.C.-based Velocity Clinical Research from NaviMed Capital and other investors. GHO is a London-based PE firm that focuses on healthcare investments. Incorporated in 2017, Velocity is an operator of 16 sites in 11 US states that conduct clinical drug trials for biopharma and contract research organizations.